Moderate‐potency vs mild‐potency topical corticosteroid
Patient‐reported symptoms of eczema · children and adults with mild to severe eczema
Moderate‐potency may leads to lower patient‐reported symptoms of eczema: 1‐5 weeks compared with mild‐potency topical corticosteroid (low certainty).
1 finding from 1 review
- Strategies for using topical corticosteroids in children and adults with eczema 2022 · Cochrane Headline outcomes onlyno estimate extracted5 studies · 449 participantsLow